» Articles » PMID: 30275265

Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2018 Oct 3
PMID 30275265
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Forced vital capacity (FVC) and DLCO are used for screening of systemic sclerosis-associated interstitial lung disease (SSc-ILD). The study purpose was to determine the sensitivity, specificity, and negative predictive value (NPV) (proportion of true negative screening tests) of FVC and DLCO thresholds for SSc-ILD on chest high-resolution computed tomography (HRCT) scans.

Methods: Patients fulfilling American College of Rheumatology 2013 SSc criteria with a chest HRCT scan and pulmonary function tests (PFT) were studied. A thoracic radiologist quantified radiographic ILD. Optimal FVC and DLCO % predicted thresholds for ILD were identified using receiver-operating characteristic curves. The FVC and DLCO combinations with greatest sensitivity and specificity were also determined. Subanalysis was performed in patients with positive Scl-70 autoantibodies.

Results: The study included 265 patients. Of 188 (71%) with radiographic ILD, 59 (31%) had "normal" FVC (≥ 80% predicted), and 65 out of 151 (43%) had "normal" DLCO (≥ 60% predicted). FVC < 80% (sensitivity 0.69, specificity 0.73), and DLCO < 62% (sensitivity 0.60, specificity 0.70) were optimal thresholds for radiographic SSc-ILD. All FVC and DLCO threshold combinations evaluated had NPV < 0.70. The NPV for radiographic ILD for FVC < 80% was lower in patients with positive Scl-70 autoantibody (NPV = 0.05) compared to negative Scl-70 autoantibody (NPV = 0.57).

Conclusion: Radiographic ILD is prevalent in SSc despite "normal" PFT. No % predicted FVC or DLCO threshold combinations yielded high NPV for SSc-ILD screening. "Normal" FVC and DLCO in patients with SSc, especially those with positive Scl-70 autoantibodies, should not obviate consideration of HRCT for ILD evaluation.

Citing Articles

Proposal of a radiation-free screening protocol for early detection of interstitial lung involvement in seropositive and ACPA-positive rheumatoid arthritis.

Reichenberger F, Popp F, Hoffmann M, Fischinger C, von Wulffen W, Kneidinger N BMC Pulm Med. 2024; 24(1):581.

PMID: 39578822 PMC: 11585148. DOI: 10.1186/s12890-024-03405-y.


Quantitative chest computed tomography predicts mortality in systemic sclerosis: A longitudinal study.

Amorim F, Dos Santos E, Yuji Verrastro C, Kayser C PLoS One. 2024; 19(9):e0310892.

PMID: 39331602 PMC: 11432915. DOI: 10.1371/journal.pone.0310892.


Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review.

Good S, Sparks J, Volkmann E Rev Colomb Reumatol. 2024; 31(Suppl 1):S3-S14.

PMID: 39238598 PMC: 11376317. DOI: 10.1016/j.rcreu.2023.06.002.


Low-Carbon Monoxide Diffusing Capacity, Patient-Reported Measures and Reduced Nailfold Capillary Density Are Associated with Interstitial Lung Disease in Systemic Sclerosis.

De Angelis R, Cipolletta E, Francioso F, Carotti M, Farah S, Giovagnoni A J Pers Med. 2024; 14(6).

PMID: 38929856 PMC: 11205232. DOI: 10.3390/jpm14060635.


The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis.

Gutierrez M, Bertolazzi C, Zozoaga-Velazquez E, Clavijo-Cornejo D Tomography. 2024; 10(4):521-532.

PMID: 38668398 PMC: 11054173. DOI: 10.3390/tomography10040041.


References
1.
Kalra M, Maher M, Rizzo S, Kanarek D, Shepard J, Shephard J . Radiation exposure from chest CT: issues and strategies. J Korean Med Sci. 2004; 19(2):159-66. PMC: 2822293. DOI: 10.3346/jkms.2004.19.2.159. View

2.
Nihtyanova S, Schreiber B, Ong V, Rosenberg D, Moinzadeh P, Coghlan J . Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol. 2014; 66(6):1625-35. DOI: 10.1002/art.38390. View

3.
van den Hoogen F, Khanna D, Fransen J, Johnson S, Baron M, Tyndall A . 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013; 65(11):2737-47. PMC: 3930146. DOI: 10.1002/art.38098. View

4.
Hankinson J, Odencrantz J, Fedan K . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999; 159(1):179-87. DOI: 10.1164/ajrccm.159.1.9712108. View

5.
MacIntyre N, Crapo R, Viegi G, Johnson D, van der Grinten C, Brusasco V . Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005; 26(4):720-35. DOI: 10.1183/09031936.05.00034905. View